Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy.

Hong S, Banchereau R, Maslow BL, Guerra MM, Cardenas J, Baisch J, Branch DW, Porter TF, Sawitzke A, Laskin CA, Buyon JP, Merrill J, Sammaritano LR, Petri M, Gatewood E, Cepika AM, Ohouo M, Obermoser G, Anguiano E, Kim TW, Nulsen J, Nehar-Belaid D, Blankenship D, Turner J, Banchereau J, Salmon JE, Pascual V.

J Exp Med. 2019 May 6;216(5):1154-1169. doi: 10.1084/jem.20190185. Epub 2019 Apr 8.

2.

Infertility treatment and risk of severe maternal morbidity: a propensity score-matched cohort study.

Dayan N, Joseph KS, Fell DB, Laskin CA, Basso O, Park AL, Luo J, Guan J, Ray JG.

CMAJ. 2019 Feb 4;191(5):E118-E127. doi: 10.1503/cmaj.181124.

3.

Effect of endometrial injury on in vitro fertilization pregnancy rates: a randomized, multicentre study.

Hilton J, Liu KE, Laskin CA, Havelock J.

Arch Gynecol Obstet. 2019 Apr;299(4):1159-1164. doi: 10.1007/s00404-019-05044-9. Epub 2019 Jan 19.

PMID:
30661093
4.

Outcome of pregnancy in women with psoriatic arthritis compared to healthy controls.

Polachek A, Polachek Shlomi I, Spitzer K, Pereira D, Ye JY, Chandran V, Laskin CA, Gladman DD.

Clin Rheumatol. 2019 Mar;38(3):895-902. doi: 10.1007/s10067-018-4385-7. Epub 2018 Dec 7.

PMID:
30535992
5.

Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus.

Barsalou J, Costedoat-Chalumeau N, Berhanu A, Fors-Nieves C, Shah U, Brown P, Laskin CA, Morel N, Levesque K, Buyon JP, Silverman ED, Izmirly PM.

Ann Rheum Dis. 2018 Dec;77(12):1742-1749. doi: 10.1136/annrheumdis-2018-213718. Epub 2018 Oct 8.

6.

Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome.

Yelnik CM, Lambert M, Drumez E, Le Guern V, Bacri JL, Guerra MM, Laskin CA, Branch DW, Sammaritano LR, Morel N, Guettrot-Imbert G, Launay D, Hachulla E, Hatron PY, Salmon JE, Costedoat-Chalumeau N.

Lupus. 2018 Sep;27(10):1679-1686. doi: 10.1177/0961203318787032. Epub 2018 Jul 17.

PMID:
30016929
7.

Severe maternal morbidity in women with high BMI in IVF and unassisted singleton pregnancies.

Dayan N, Fell DB, Guo Y, Wang H, Velez MP, Spitzer K, Laskin CA.

Hum Reprod. 2018 Jul 3. doi: 10.1093/humrep/dey224. [Epub ahead of print]

PMID:
29982477
8.

Maternal and Fetal Outcomes in a Cohort of Patients Exposed to Tumor Necrosis Factor Inhibitors throughout Pregnancy.

Genest G, Spitzer KA, Laskin CA.

J Rheumatol. 2018 Aug;45(8):1109-1115. doi: 10.3899/jrheum.171152. Epub 2018 Jul 1.

PMID:
29961692
9.

Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.

Kim MY, Guerra MM, Kaplowitz E, Laskin CA, Petri M, Branch DW, Lockshin MD, Sammaritano LR, Merrill JT, Porter TF, Sawitzke A, Lynch AM, Buyon JP, Salmon JE.

Ann Rheum Dis. 2018 Apr;77(4):549-555. doi: 10.1136/annrheumdis-2017-212224. Epub 2018 Jan 25.

10.

Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study.

Barsalou J, Jaeggi E, Laskin CA, Brown P, Tian SY, Hamilton RM, Silverman ED.

Rheumatology (Oxford). 2017 Sep 1;56(9):1552-1559. doi: 10.1093/rheumatology/kex191.

PMID:
28595349
11.

Contribution of Socioeconomic Status to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus.

Kaplowitz ET, Ferguson S, Guerra M, Laskin CA, Buyon JP, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Merrill JT, Katz P, Salmon JE.

Arthritis Care Res (Hoboken). 2018 Feb;70(2):230-235. doi: 10.1002/acr.23263. Epub 2017 Dec 29.

12.

Safety and Efficacy of in Vitro Fertilization in Women with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.

Genest G, Laskin CA.

J Rheumatol. 2017 May;44(5):547-549. doi: 10.3899/jrheum.170064. No abstract available.

PMID:
28461516
13.

Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus.

Buyon JP, Kim MY, Guerra MM, Lu S, Reeves E, Petri M, Laskin CA, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Sawitzke A, Merrill JT, Stephenson MD, Cohn E, Salmon JE.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):940-946. doi: 10.2215/CJN.11431116. Epub 2017 Apr 11.

14.

Changes in Circulating ProAMH and Total AMH during Healthy Pregnancy and Post-Partum: A Longitudinal Study.

Pankhurst MW, Clark CA, Zarek J, Laskin CA, McLennan IS.

PLoS One. 2016 Sep 9;11(9):e0162509. doi: 10.1371/journal.pone.0162509. eCollection 2016.

15.

A young woman with early pregnancy loss.

Laskin CA, Spitzer KA.

CMAJ. 2017 Jan 9;189(1):E17-E18. doi: 10.1503/cmaj.151092. Epub 2016 Aug 29. No abstract available.

16.

Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes.

Yelnik CM, Porter TF, Branch DW, Laskin CA, Merrill JT, Guerra MM, Lockshin MD, Buyon JP, Petri M, Sammaritano LR, Stephenson MD, Kim MY, Salmon JE.

Arthritis Rheumatol. 2016 Aug;68(8):1964-9. doi: 10.1002/art.39668.

17.

A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia.

Skeith L, Carrier M, Kaaja R, Martinelli I, Petroff D, Schleußner E, Laskin CA, Rodger MA.

Blood. 2016 Mar 31;127(13):1650-5. doi: 10.1182/blood-2015-12-626739. Epub 2016 Feb 2. Review.

PMID:
26837697
18.

Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results.

Yelnik CM, Laskin CA, Porter TF, Branch DW, Buyon JP, Guerra MM, Lockshin MD, Petri M, Merrill JT, Sammaritano LR, Kim MY, Salmon JE.

Lupus Sci Med. 2016 Jan 12;3(1):e000131. doi: 10.1136/lupus-2015-000131. eCollection 2016.

19.

Effect of chronic hypertension on assisted pregnancy outcomes: a population-based study in Ontario, Canada.

Dayan N, Lanes A, Walker MC, Spitzer KA, Laskin CA.

Fertil Steril. 2016 Apr;105(4):1003-9. doi: 10.1016/j.fertnstert.2015.11.039. Epub 2015 Dec 12.

PMID:
26690007
20.

Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.

Kim MY, Buyon JP, Guerra MM, Rana S, Zhang D, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Merrill JT, Stephenson MD, Gao Q, Karumanchi SA, Salmon JE.

Am J Obstet Gynecol. 2016 Jan;214(1):108.e1-108.e14. doi: 10.1016/j.ajog.2015.09.066. Epub 2015 Sep 29.

21.

A Focus on Maternal Health Before Assisted Reproduction: Results From a Pilot Survey of Canadian IVF Medical Directors.

Dayan N, Spitzer K, Laskin CA.

J Obstet Gynaecol Can. 2015 Jul;37(7):648-655. doi: 10.1016/S1701-2163(15)30204-8.

PMID:
26366823
22.

Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.

Buyon JP, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, Sammaritano L, Branch DW, Porter TF, Sawitzke A, Merrill JT, Stephenson MD, Cohn E, Garabet L, Salmon JE.

Ann Intern Med. 2015 Aug 4;163(3):153-63. doi: 10.7326/M14-2235.

23.

In vitro culture conditions, antiphospholipid antibodies and trophoblast function.

Clark CA, Laskin CA.

Hum Reprod Update. 2015 May-Jun;21(3):406-7. doi: 10.1093/humupd/dmv005. Epub 2015 Feb 2. No abstract available.

PMID:
25646209
24.

Obstetric antiphospholipid syndrome: has the black swan swallowed a red herring?

Clark CA, Spitzer KA, Laskin CA.

J Rheumatol. 2015 Feb;42(2):155-7. doi: 10.3899/jrheum.140760. No abstract available.

PMID:
25641965
25.

Pregnancy complications in women with heart disease conceiving with fertility therapy.

Dayan N, Laskin CA, Spitzer K, Mason J, Udell JA, Wald RM, Siu SC, Iten-Scott T, Silversides CK.

J Am Coll Cardiol. 2014 Oct 28;64(17):1862-4. doi: 10.1016/j.jacc.2014.07.977. Epub 2014 Oct 21. No abstract available.

26.

Ovarian reserve in antiphospholipid syndrome: the jury is still out.

Clark CA, Laskin CA.

Lupus. 2015 Jun;24(7):773. doi: 10.1177/0961203314560206. Epub 2014 Nov 12. No abstract available.

PMID:
25391544
27.

Unrealistic estimation of population prevalence of antiphospholipid antibody-related pregnancy loss: comment on the article by Andreoli et al.

Clark CA, Laskin CA.

Arthritis Care Res (Hoboken). 2014 Jun;66(6):966. doi: 10.1002/acr.22273. No abstract available.

28.

Anti-Mullerian hormone: reality check.

Clark CA, Laskin CA, Cadesky K.

Hum Reprod. 2014 Jan;29(1):184-5. doi: 10.1093/humrep/det413. Epub 2013 Nov 13. No abstract available.

PMID:
24227077
29.

The transfer of pravastatin in the dually perfused human placenta.

Zarek J, DeGorter MK, Lubetsky A, Kim RB, Laskin CA, Berger H, Koren G.

Placenta. 2013 Aug;34(8):719-21. doi: 10.1016/j.placenta.2013.05.002. Epub 2013 Jun 5.

PMID:
23746925
30.

The lupus anticoagulant: results from 2257 patients attending a high-risk pregnancy clinic.

Clark CA, Davidovits J, Spitzer KA, Laskin CA.

Blood. 2013 Jul 18;122(3):341-7; quiz 466. doi: 10.1182/blood-2013-02-485839. Epub 2013 May 6.

PMID:
23649468
31.

Fertility and pregnancy in vasculitis.

Pagnoux C, Mahendira D, Laskin CA.

Best Pract Res Clin Rheumatol. 2013 Feb;27(1):79-94. doi: 10.1016/j.berh.2013.02.002. Review.

PMID:
23507059
32.

Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence.

Clark CA, Laskin CA, Spitzer KA.

Hum Reprod Update. 2012 Sep-Oct;18(5):474-84. doi: 10.1093/humupd/dms020. Epub 2012 Jun 13.

PMID:
22699010
33.

Idiopathic recurrent miscarriage is caused mostly by aneuploid embryos.

Hodes-Wertz B, Grifo J, Ghadir S, Kaplan B, Laskin CA, Glassner M, Munné S.

Fertil Steril. 2012 Sep;98(3):675-80. doi: 10.1016/j.fertnstert.2012.05.025. Epub 2012 Jun 7.

PMID:
22683012
34.

Use of non-aspirin NSAIDs during pregnancy may increase the risk of spontaneous abortion.

Verma P, Clark CA, Spitzer KA, Laskin CA, Ray J, Koren G.

Evid Based Nurs. 2012 Jul;15(3):76-7. doi: 10.1136/ebnurs-2011-100439. Epub 2012 Mar 12. No abstract available.

PMID:
22411163
35.

Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.

Lockshin MD, Kim M, Laskin CA, Guerra M, Branch DW, Merrill J, Petri M, Porter TF, Sammaritano L, Stephenson MD, Buyon J, Salmon JE.

Arthritis Rheum. 2012 Jul;64(7):2311-8. doi: 10.1002/art.34402.

36.

Spontaneous abortion and NSAIDs.

Clark CA, Spitzer KA, Laskin CA, Koren G.

CMAJ. 2011 Dec 13;183(18):2145; author reply 2145-6. doi: 10.1503/cmaj.111-2092. No abstract available.

37.

Obstetric antiphospholipid syndrome: conclusions confounded by small sample sizes and uncertain antibody profiles.

Clark CA, Laskin CA, Spitzer KA.

J Matern Fetal Neonatal Med. 2012 Aug;25(8):1521. doi: 10.3109/14767058.2011.633670. Epub 2011 Nov 25. No abstract available.

PMID:
22117118
38.

Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss.

Clark CA, Spitzer KA, Laskin CA, Crowther MR, Ginsberg JS.

Obstet Gynecol. 2010 Oct;116(4):997-8; author reply 998. doi: 10.1097/AOG.0b013e3181f4e012. No abstract available.

PMID:
20859172
39.

Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.

Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA, Kingdom JC, Barrett J, Gent M.

J Rheumatol. 2009 Feb;36(2):279-87. doi: 10.3899/jrheum.080763).

PMID:
19208560
40.

Incidence of postpartum thrombosis and preterm delivery in women with antiphospholipid antibodies and recurrent pregnancy loss.

Clark CA, Spitzer KA, Crowther MA, Nadler JN, Laskin MD, Waks JA, Laskin CA.

J Rheumatol. 2007 May;34(5):992-6. Epub 2007 Apr 1.

PMID:
17407219
41.

Postpartum management of women at increased risk of thrombosis--results of a Canadian pilot survey.

Spitzer KA, Murphy K, Crowther M, Clark CA, Laskin CA.

J Rheumatol. 2006 Nov;33(11):2222-6. Epub 2006 Sep 15.

PMID:
16981294
42.

Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period.

Clark CA, Spitzer KA, Laskin CA.

J Rheumatol. 2005 Sep;32(9):1709-12.

PMID:
16142865
43.

Potential adverse effect of sperm DNA damage on embryo quality after ICSI.

Zini A, Meriano J, Kader K, Jarvi K, Laskin CA, Cadesky K.

Hum Reprod. 2005 Dec;20(12):3476-80. Epub 2005 Aug 25.

PMID:
16123087
44.

Antiphospholipid syndrome in systemic lupus erythematosus: is the whole greater than the sum of its parts?

Laskin CA, Clark CA, Spitzer KA.

Rheum Dis Clin North Am. 2005 May;31(2):255-72, vi. Review.

PMID:
15922145
45.

Binucleated and micronucleated blastomeres in embryos derived from human assisted reproduction cycles.

Meriano J, Clark C, Cadesky K, Laskin CA.

Reprod Biomed Online. 2004 Nov;9(5):511-20.

PMID:
15588469
46.

Recurrent pregnancy loss in the context of antiphospholipid antibodies: comment on the article by Triolo et al.

Laskin CA, Clark CA, Spitzer KA.

Arthritis Rheum. 2004 Mar;50(3):1017-8. No abstract available.

47.

Preterm deliveries in women with systemic lupus erythematosus.

Clark CA, Spitzer KA, Nadler JN, Laskin CA.

J Rheumatol. 2003 Oct;30(10):2127-32.

PMID:
14528505
48.

The spectrum of the antiphospholipid syndrome: a matter of perspective.

Clark CA, Spitzer KA, Laskin CA.

J Rheumatol. 2001 Sep;28(9):1939-41. No abstract available.

PMID:
11550956
49.

In vitro thrombin generation.

Clark-Soloninka CA, Laskin CA.

J Rheumatol. 2001 Apr;28(4):919-20. No abstract available.

PMID:
11327278
50.

Supplemental Content

Loading ...
Support Center